Weight Loss And ...

Most people trying to lose weight obsess over the what: what diet, what medication, what workout plan. But according to Holly and Jim, the real key to long-term success isn't found in any of those choices. It's found in a set of decisions most people never even realize they're making.
In this episode, Holly and Jim count down the 10 decisions that determine whether a weight loss journey actually sticks. Some are questions you'd expect. Others might catch you completely off guard, including the one they say most listeners will never predict is number one.
Whether you're just starting, deep into a GLP-1 medication, working to maintain weight you've already lost, or wondering if you're on the right plan at all, this countdown is built for you. So before you make your next move, find out if you've quietly been making these decisions by default or on purpose.
Discussed on the episode:
The very first decision Holly says most people skip entirely and why it might surprise you coming from two people who host a weight loss podcast.
Why a number on the scale might not mean what you think it means, and what "success" should really be measured by
A newer, often-overlooked decision that's only become critical in the age of powerful weight loss medications
The mindset shift that separates people who keep weight off from those who regain it
Why hitting a plateau might actually be a sign you're succeeding, not failing.
The surprising, deeply personal decision Holly and Jim rank as number one one they say most listeners will guess wrong

For years, the ceiling on medical weight loss was 15%, maybe 20% if you were lucky. Now a new triple-target medication is posting average results that flirt with 30% body weight loss in clinical trials, numbers once reserved for the operating room. Holly and Jim sat down to unpack what's driving these results, and found themselves asking a question neither expected to ask in their careers: how much weight loss is actually too much?
Retatrutide, the drug at the center of this episode, adds a third receptor target to the GLP-1 and GIP combination already familiar to listeners. Holly and Jim break down what this third piece brings to the table, walk through the newest published and presented trial data, and get refreshingly honest about the parts of this "medical miracle" that keep them up at night.
More weight loss isn't automatically better weight loss. As these medications get more powerful, Holly and Jim argue the field needs to catch up fast on nutrition, dosing, and what "success" even means going forward. If you've been following the GLP-1 story, this episode is the plot twist you didn't see coming.
Discussed on the episode:
What makes this new medication a "triple agonist," and why adding a hormone best known for raising blood sugar might actually help with weight loss.
The eye-opening trial results that have researchers using words like "mind-blowing" and why the number didn't plateau the way older treatments do
A surprising new clinical worry that Holly never thought she'd hear herself say out loud
Why "maximum dose" might not be the right goal for most people, even though it produces the biggest numbers
The uncomfortable side effect that showed up more with this medication than with anything else on the market
Whether switching medications is a good idea if what you're currently using is already working.
The philosophical question Holly and Jim now find themselves asking about appetite itself and why silencing it completely might not be a win.
A hint at what's coming next in obesity treatment, involving a hormone that hasn't entered the conversation yet

Can simply paying attention to your first bite of food change how much you eat? It sounds too simple to matter, but Holly and Jim are digging into a topic that might seem completely outside their lane: mindfulness and meditation.
For years, mindfulness has been filed under "stress management," not "weight management." But a growing body of research is asking a bigger question: can training the mind actually change the way we eat, not by altering our biology, but by changing how we respond to it? Holly and Jim break down a recent meta-analysis of dozens of studies to find out what's real, what's hype, and where this surprisingly powerful tool might fit into your own weight loss journey, especially the part everyone struggles with most: keeping the weight off.
Tune in as Holly and Jim separate the science from the sales pitch, tackle listener questions, and even reveal a personal update that might surprise you.
Discussed on the episode
Why "eating on autopilot" happens to all of us and the moment Holly realized she was already halfway through a road trip sandwich she didn't remember eating
The surprising reason automatic eating exists in the first place (hint: it's not laziness)
What a 46-study meta-analysis reveals about mindfulness and eating behavior and why the effect is small but might matter more than you'd think
Why this tool may matter far more for keeping weight off than for losing it in the first place
The key difference between mindfulness and meditation (and why they get confused)
A concept called "decentering" that could change the way you handle cravings
Whether mindful eating is secretly just another diet in disguise
One simple, five-minute-a-day habit almost anyone can start today.
A rapid-fire round covering hunger vs. habit, biology vs. behavior, and myths about needing to "sit quietly with your eyes closed"
A personal confession from Jim about a new daily practice he's been keeping quiet about

A few clicks online. No exam, no phone call, no video visit. Minutes later, a GLP-1 prescription is headed to your door. It sounds like the future of healthcare: fast, easy, convenient. But is convenience the same thing as care?
A Yale research team wanted to find out, so they built a fake patient, sent her to 49 different online GLP-1 providers, and tracked exactly what happened. What they found may change the way you think about getting these medications online and raise questions you didn't know to ask.
Join Holly and Jim as they unpack this eye-opening "secret shopper" study and use it to explore a much bigger question: when does convenience actually improve obesity care, and when does it quietly replace it? Whether you're currently taking a GLP-1, considering one, or just curious about where obesity treatment is headed, this episode will change how you evaluate any provider online or in person.
Discussed on the episode:
The surprising percentage of online providers that approved a prescription in some cases in under five minutes
The critical questions almost none of the 49 companies bothered to ask before prescribing a powerful medication
Why "getting the meds" and "getting obesity care" are two very different things
The real risks of starting a GLP-1 without a proper medical evaluation
What compounded GLP-1s are, and why the vast majority of online prescriptions turned out to be compounded rather than brand-name
Why your primary care doctor absolutely needs to know you're taking one of these medications (even if your online provider never asks)
The dose-escalation practice that has Holly worried and why more medication isn't always better
Holly and Jim's personal, unscripted stories about when convenience backfired in their own lives
A simple framework for evaluating whether an online (or in-person) provider is actually giving you the care you deserve

For years, patients kept telling Holly the same strange thing: it wasn't the number on the scale that changed their life, it was something quieter, something they'd never had words for. They just didn't think about food anymore.
Now that experience has a name, and for the first time, a way to measure it. Food noise has gone from an offhand comment on social media to one of the most talked-about concepts in obesity science, and Holly and Jim are back to unpack how far the research has come since they last covered it.
Join Holly and Jim as they revisit food noise with fresh eyes. You'll hear how a handful of scattered patient stories turned into a full-blown scientific movement, what the newest validated tools can actually tell us, and why this "invisible" part of obesity might reshape how we think about treatment for years to come. Along the way, Holly and Jim get personal, sharing their own honest (and sometimes surprising) answers to whether they experience food noise themselves.
Discussed on the episode:
How an unexpected side effect of GLP-1 medications turned into a full-blown scientific mystery
The difference between food noise, hunger, and cravings, and why it matters more than you'd think
Two newly validated tools researchers are using to measure something patients have described for years.
A surprising decades-old study that raises the question: is food noise really new?
A science-backed framework for understanding where food noise comes from in the brain
Whether food noise could predict who regains weight, and who doesn't
The big philosophical question: could reducing food noise become a treatment goal, even for people who don't need to lose weight?
Holly and Jim's own personal, no-holds-barred answers to "do you have food noise?"
What might happen to food noise if you stop taking a GLP-1 medication, and whether that means treatment "failed"